Effects of antihypertensive treatment on left ventricular hypertrophy in patients with essential hypertension.
D000328:Adult; D000368:Aged; D000818:Animals; D000959:Antihypertensive Agents / Q000494:pharmacology* / Q000627:therapeutic use; D006332:Cardiomegaly / Q000188:drug therapy / Q000209:etiology / Q000517:prevention & control*; D004562:Electrocardiography; D005260:Female; D006352:Heart Ventricles / Q000187:drug effects; D006801:Humans; D006830:Hydralazine / Q000494:pharmacology / Q000627:therapeutic use; D006973:Hypertension / Q000150:complications / Q000188:drug therapy*; D008297:Male; D008750:Methyldopa / Q000494:pharmacology / Q000627:therapeutic use; D008875:Middle Aged; D011433:Propranolol / Q000494:pharmacology / Q000627:therapeutic use; D051381:Rats; D014237:Trichlormethiazide / Q000494:pharmacology / Q000627:therapeutic use
D000959:Antihypertensive Agents; D006830:Hydralazine; D008750:Methyldopa; D011433:Propranolol; D014237:Trichlormethiazide